{"count": 3, "results": [{"_id": "34047916", "pmid": 34047916, "title": "Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial.", "journal": "Adv Ther", "authors": ["Tauqir S", "Israr M", "Rauf B", "Malik MO", "Habib SH", "Shah FA", "Usman M", "Raza MA", "Shah I", "Badshah H", "Ehtesham E", "Shah M"], "date": "2021-07-01T00:00:00Z", "doi": "10.1007/s12325-021-01789-5", "meta_date_publication": "2021 Jul", "meta_volume": "38", "meta_issue": "7", "meta_pages": "3842-3856", "score": 50242.31, "text_hl": "CONCLUSION: We conclude that addition of @CHEMICAL_Acetylcarnitine @CHEMICAL_MESH:D000108 @@@ALC@@@ therapy is superior to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ in ameliorating @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovaries@@@, menstrual irregularities, and @<m>DISEASE_Hypoadiponectinemia</m> @DISEASE_MESH:C567258 @@@hypoadiponectinemia@@@ in @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@. ", "citations": {"NLM": "Tauqir S, Israr M, Rauf B, Malik MO, Habib SH, Shah FA, Usman M, Raza MA, Shah I, Badshah H, Ehtesham E, Shah M. Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial. Adv Ther. 2021 Jul;38(7):3842-3856. PMID: 34047916", "BibTeX": "@article{34047916, title={Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial.}, author={Tauqir S and Israr M and Rauf B and Malik MO and Habib SH and Shah FA and Usman M and Raza MA and Shah I and Badshah H and Ehtesham E and Shah M}, journal={Adv Ther}, volume={38}, number={7}, pages={3842-3856}}"}}, {"_id": "23497197", "pmid": 23497197, "pmcid": "PMC3606629", "title": "Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats", "journal": "Cardiovasc Diabetol", "authors": ["Schmid PM", "Resch M", "Schach C", "Birner C", "Riegger GA", "Luchner A", "Endemann DH"], "date": "2013-03-18T00:00:00Z", "doi": "10.1186/1475-2840-12-46", "meta_date_publication": "2013 Mar 18", "meta_volume": "12", "meta_issue": "", "meta_pages": "46", "score": 50072.375, "text_hl": "An antidiabetic treatment with either @GENE_INS @GENE_3630 @@@insulin@@@ or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in ZDF @SPECIES_10116 @@@rats@@@ inhibits the development of @<m>DISEASE_Hypoadiponectinemia</m> @DISEASE_MESH:C567258 @@@hypoadiponectinemia@@@ and downregulation of @GENE_APPL1 @GENE_290537 @@@APPL1@@@ in mesenteric resistance arteries, but is not able to improve @GENE_ADIPOQ @GENE_246253 @@@adiponectin@@@ induced vasodilation and @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@. ", "citations": {"NLM": "Schmid PM, Resch M, Schach C, Birner C, Riegger GA, Luchner A, Endemann DH. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats Cardiovasc Diabetol. 2013 Mar 18;12():46. PMID: 23497197", "BibTeX": "@article{23497197, title={Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats}, author={Schmid PM and Resch M and Schach C and Birner C and Riegger GA and Luchner A and Endemann DH}, journal={Cardiovasc Diabetol}, volume={12}, pages={46}}"}}, {"_id": "16953257", "pmid": 16953257, "title": "Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.", "journal": "Int J Obes (Lond)", "authors": ["Fu JF", "Liang L", "Zou CC", "Hong F", "Wang CL", "Wang XM", "Zhao ZY"], "date": "2007-01-01T00:00:00Z", "doi": "10.1038/sj.ijo.0803453", "meta_date_publication": "2007 Jan", "meta_volume": "31", "meta_issue": "1", "meta_pages": "15-22", "score": 50048.59, "text_hl": "Thirty out of thirty-six @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MS@@@ subjects with age over 10 years received @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment combined with lifestyle modification. ", "citations": {"NLM": "Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM, Zhao ZY. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes (Lond). 2007 Jan;31(1):15-22. PMID: 16953257", "BibTeX": "@article{16953257, title={Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.}, author={Fu JF and Liang L and Zou CC and Hong F and Wang CL and Wang XM and Zhao ZY}, journal={Int J Obes (Lond)}, volume={31}, number={1}, pages={15-22}}"}}]}